Sign in

NCT06541860Recruiting

DAratumumab and REvlimid REfractory MM

Salvage Regimens in Multiple Myeloma Patients Double Refractory to Lenalidomide and MoAbs: Evidence From Real World Experience

Source: ClinicalTrials.gov · Last updated 7 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Retrospective and prospective multicenter observational study on patients with relapsed and refractory multiple myeloma after anti-CD38 MoAb therapy and IMIDS treated with onlabel regimens.

Status (registry)
Recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
9 Apr 2024
Start date
21 Aug 2023
Primary completion date
21 Feb 2028
Lead sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
NCT number
NCT06541860

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 21 Aug 2023 to the primary completion date, 21 Feb 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients not willing to consent to review of clinical data

Who the study is looking for

  • Phase I
  • Patients with RRMM after therapy with anti-CD38 MoAb plus IMIDS started on therapy with PVD scheme
  • Patients aged ≥ 18 years
  • Patients able to understand and voluntarily sign an informed consent and be willing to consent to the review of clinical data
    • Phase II
  • Patients with RRMM after first-line therapy with anti-CD38 MoAb plus IMIDS started on therapy with on-label schemes
  • Patients aged ≥ 18 years
  • Patients able to understand and voluntarily sign an informed consent and be willing to consent to the review of clinical data

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Irccs San Matteo Pavia
Coordinator of this site? Confirm its status
PaviaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.